MoonLake Immunotherapeutics
MLTX
MLTX
24 hedge funds and large institutions have $291M invested in MoonLake Immunotherapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.42%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
4
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
